HCW Biologics Inc (HCWB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.73M
Last updated: Nov 17, 2026 at 4:33 PM ET
HCW Biologics Inc (HCWB) Stock Chart
HCW Biologics (HCWB) has a latest price of $0.76 on Nov 17, 2026, 96.8% below its 52-week high of $23.94. Its price fell 95.8% over the past 12 months. The month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 74.8%.
Price Chart
From Jul 2021 to Oct 2026, its highest month-end close was $1,192.32 in Jul 2021 and its lowest $1.10 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart HCWB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HCWB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 67.1%, and over 6 months it fell 88.1%. The month-end price fell 99.7% over the 3 years through Oct 2026, a compound annual decline of 86.0%.
| Period | Change |
|---|---|
| 1 month | -38.4% |
| 3 months | -67.1% |
| 6 months | -88.1% |
| 12 months | -95.8% |
| 12 months, with dividends | -95.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -99.7% | -86.0% |
| 5 years | -99.9% | -74.8% |
Price by Year
Its best calendar year was 2022, when the price fell 17.5%, and its weakest was 2025, when it fell 94.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.10 | -81.1% |
| 2025 | $5.82 | -94.6% |
| 2024 | $107.04 | -63.6% |
| 2023 | $293.94 | -36.0% |
| 2022 | $459.46 | -17.5% |
Trading Range
The price is 47.6% below its 50-day average of $1.45 and 79.6% below its 200-day average of $3.72.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.76 | |
| 52-week high | $23.94 | -96.8% |
| 52-week low | $0.74 | +2.0% |
| 50-day average | $1.45 | -47.6% |
| 200-day average | $3.72 | -79.6% |
Price Risk
Over 3 years, its largest fall from a peak was 99.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.12 |
| Largest fall, 1 year | -95.9% |
| Largest fall, 3 years | -99.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About HCWB
What is HCWB's 1-year price change?
HCW Biologics's price fell 95.8% over the past 12 months. With dividends included, the 12-month total return was -95.8%.
What is HCWB's 5-year price change?
HCW Biologics's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 74.8%. These figures leave out dividends.
What is HCWB's 52-week high and low?
HCW Biologics's 52-week high is $23.94 and its 52-week low is $0.74. Its latest price of $0.76 on Nov 17, 2026 is 96.8% below the high.
What is HCWB's beta?
HCW Biologics's 1-year beta against the S&P 500 is 1.12, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 95.9%.
Is the HCWB chart free?
Yes. Advanced Charting for HCWB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
HCWB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors